- 1 December 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (12) , 2846-2855
Abstract
BACKGROUND: An increasing number of monogenic conditions underlying stroke are being identified. We explored the possibilities of increasing the diagnostic yield of monogenic stroke in a population under 56 years of age. METHODS: Fifty probands ≤55 years at their first stroke episode were characterized clinically and investigated by whole genome sequencing. Probands had one or more of: (1) one or more first to second degree relatives with stroke under 60 years or same stroke-causing condition/disease; (2) no hypertension, hypercholesterolemia, diabetes, heart disease, or smoking; or (3) either multiple stroke episodes or multiple arterial dissections. Variants with minor allele frequency under 0.01, identified by using our stroke gene panels, were assessed. The stroke subtypes, including large artery atherosclerotic, large artery nonatherosclerotic (tortuosity, dolichoectasia, aneurysm, nonatherosclerotic dissection, or occlusion), cerebral small vessel disease, cardioembolic (arrhythmia, heart defect, or cardiomyopathy), coagulation dysfunctions (venous thrombosis, arterial thrombosis, or bleeding tendency), intracerebral hemorrhage, vascular malformations (cavernoma or arteriovenous malformations), metabolic disorders, or cryptogenic embolic, were used for genotype-phenotype correlation. In a final step, we combined genetic and clinical information to determine if the genetic variant likely was the cause of stroke in the patients. RESULTS: Whole genome sequencing of younger patients with stroke identified 17 clinically matching genetic variants in 15 of 50 (30%) patients, while a stronger clinical correlation with stroke was established in only 6 (12%) of them. Stroke-related genetic variants were identified in 4 of 5 (80%) patients with cardioembolic stroke subtype, 3 of 4 (75%) with intracerebral hemorrhage, 7 of 18 (39%) with cryptogenic embolic stroke, 1 of 6 (17%) with small vessel disease, and 3 of 15 (20%) of patients with nonatherosclerotic large artery stroke, including 1 of 11 (9%) with cervical dissection stroke. CONCLUSIONS: Careful clinical interpretation of whole genome data using stroke gene panels can detect monogenic causes of early stroke, allowing individualized follow-up and opening new possibilities for potential treatment.Keywords
This publication has 54 references indexed in Scilit:
- De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset strokeGenetics in Medicine, 2023
- Monogenic Causes in Familial Stroke Across Intracerebral Hemorrhage and Ischemic Stroke Subtypes Identified by Whole-Exome SequencingCellular and Molecular Neurobiology, 2022
- Association of genetic variants of RNF213 with ischemic stroke risk in KoreansGenes & Genomics, 2021
- Targeted re-sequencing in pediatric and perinatal strokeEuropean Journal of Medical Genetics, 2020
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP GuidelinesThe American Journal of Human Genetics, 2017
- Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controlsEuropean Journal of Epidemiology, 2013
- Characterization of Collagen Thin Films for von Willebrand Factor Binding and Platelet AdhesionLangmuir, 2011
- Two novel mutations in the β-Myosin Heavy Chain Gene Associated with Dilated CardiomyopathyEuropean Journal of Heart Failure, 2004
- Aneurysmal sub-arachnoid haemorrhage in patients with Noonan syndrome: a report of two cases and review of neurovascular presentations in this syndromeNeuroradiology, 2004